Acute lymphoblastic leukaemia (ALL)

• Health & Medicine
• Science & Technology

Could the gut microbiome play a key role in preventing childhood leukaemia?

The microbiome is made up of trillions of microbes, including bacteria, fungi and even viruses. A research group believes this bustling community could be the key for preventing childhood acute lymphoblastic leukaemia. The microbiome is made up of trillions of microbes, including bacteria, fungi and even viruses. A research group believes this bustling community could be the key for preventing childhood acute lymphoblastic leukaemia.

3 January 2024

• Health & Medicine

Children’s cancer charities team up for tomorrow’s treatments

We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people. We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.

3 April 2023

• Science & Technology

The link between Down syndrome and childhood leukaemia

In 1930, it was discovered that children with Down syndrome are at a greater risk of developing certain types of leukaemia, but much of our understanding of this link remains a mystery. In 1930, it was discovered that children with Down syndrome are at a greater risk of developing certain types of leukaemia, but much of our understanding of this link remains a mystery.

1 September 2022

• Health & Medicine

Cancer in children and young people: how far we’ve come

Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers. Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers.

29 September 2021

• Health & Medicine

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

26 March 2020

• Health & Medicine

NICE U-turn opens up new treatment option for some adults with leukaemia

Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England. Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.

19 June 2019

• Health & Medicine

Leukaemia drug gets initial ‘no’ for NHS in England

Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England. Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England.

6 March 2019

• Health & Medicine

Double NHS decision for CAR T cell immunotherapy in Scotland

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer. Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

13 February 2019

• Health & Medicine

First patient receives CAR T cell therapy on NHS

An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS. An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS.

31 January 2019

• Personal Stories

Chelsea legend Gianfranco Zola surprises Blues fan and cancer survivor

Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto

18 October 2018

• Health & Medicine

NHS England to fund personalised blood cancer immunotherapy

A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today. A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today.

5 September 2018